Mr. Wegter became a member and chairman of our Supervisory Board in 2001. Mr. Wegter graduated from the Erasmus University of Rotterdam, The Netherlands with a degree in economics. In 1998, Mr. Wegter joined Life Sciences Partners,becoming a general partner in 2001. In that same year Mr. Wegter established Life Sciences Partners’ office in Munich, Germany.

Mr. Kleijwegt became a member of our Supervisory Board in 2006. Mr. Kleijwegt graduated from the University of Amsterdam, The Netherlands with a degree in economics. Mr. Kleijwegt founded Life Sciences Partners in 1998 and has been managing partner of Life Sciences Partners since that date.

Dr. Smirnyagina became a member of our Supervisory Board in 2007. Dr. Smirnyagina graduated from Moscow State University, Russia with a degree in biochemistry and obtained a PhD in cellular and molecular biology from the University of Wisconsin-Madison, USA. Dr. Smirnyagina joined Alta Partners in 2002 and became a venture partner in 2006.

Mr. Skaletsky became a member of our supervisory board in December 2008. He served as president and CEO of GelTex Pharmaceuticals, Inc. (acquired by Genzyme for more than $1 billion in December 2000), chairman and CEO of Enzytech, Inc., and president and Chief Operating Officer of Biogen, Inc. He is also a former chairman of the board of directors of the Biotechnology Industry Organization (BIO). Mr. Skaletsky is chairman, CEO and president of Fenway Pharmaceuticals, Inc.